Symbols / NRXS Stock $7.25 +0.97% NeurAxis, Inc.
NRXS (Stock) Chart
About
NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 8 years of age with functional abdominal pain associated with irritable bowel syndrome (IBS), functional dyspepsia (FD) and associated FD nausea symptoms. The company also offers rectal expulsion device, a screening tool that helps to detects evacuation disorders. It sells its products to healthcare companies, such as hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. NeurAxis, Inc. was founded in 2011 and is headquartered in Carmel, Indiana.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Biotechnology | Market Cap | 81.11M |
| Enterprise Value | 76.58M | Income | -8.62M | Sales | 3.57M |
| Book/sh | 0.32 | Cash/sh | 0.44 | Dividend Yield | — |
| Payout | 0.00% | Employees | 24 | IPO | — |
| P/E | — | Forward P/E | -362.50 | PEG | — |
| P/S | 22.72 | P/B | 22.73 | P/C | — |
| EV/EBITDA | -10.72 | EV/Sales | 21.45 | Quick Ratio | 1.85 |
| Current Ratio | 2.05 | Debt/Eq | 12.55 | LT Debt/Eq | — |
| EPS (ttm) | -0.95 | EPS next Y | -0.02 | EPS Growth | — |
| Revenue Growth | 27.20% | Earnings | 2026-03-19 07:00 | ROA | -80.63% |
| ROE | -285.36% | ROIC | — | Gross Margin | 84.23% |
| Oper. Margin | -177.34% | Profit Margin | -218.55% | Shs Outstand | 11.19M |
| Shs Float | 7.53M | Short Float | 1.79% | Short Ratio | 1.02 |
| Short Interest | — | 52W High | 7.97 | 52W Low | 1.33 |
| Beta | 1.89 | Avg Volume | 149.24K | Volume | 42.47K |
| Target Price | $11.00 | Recom | None | Prev Close | $7.18 |
| Price | $7.25 | Change | 0.97% |
Valuation Models
Price estimates from analyst targets and simple models.
Ratings
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2026-03-20 | main | Craig-Hallum | Buy → Buy | $13 |
| 2025-12-22 | main | Craig-Hallum | Buy → Buy | $8 |
| 2025-06-16 | init | Craig-Hallum | — → Buy | $7 |
- Insider Purchase: Chief Financial Officer of $NRXS Buys 7,593 Shares - Quiver Quantitative Fri, 03 Apr 2026 15
- Neuraxis (NRXS) CFO acquires 7,593 shares at $1.96 in open trade - Stock Titan Fri, 03 Apr 2026 15
- Insider Buying: NeurAxis (NASDAQ:NRXS) CFO Buys 7,593 Shares of Stock - MarketBeat Fri, 03 Apr 2026 16
- Neuraxis CFO Henrichs buys $14,882 in company stock - Investing.com Fri, 03 Apr 2026 15
- Top NeurAxis Insiders Make Bold Moves With Fresh Stock Buys - TipRanks Sat, 04 Apr 2026 02
- Neuraxis (NRXS) executive makes small open-market share purchase - Stock Titan Fri, 03 Apr 2026 15
- NeurAxis Stock Gains Post Q4 Earnings on Strong Revenue Growth - zacks.com ue, 24 Mar 2026 07
- NRXS PE Ratio & Valuation, Is NRXS Overvalued - Intellectia AI Sat, 04 Apr 2026 14
- $NRXS stock is down 11% today. Here's what we see in our data. - Quiver Quantitative hu, 19 Mar 2026 07
- Neuraxis Inc: CRO Carrico buys $1307 in shares - Investing.com Fri, 03 Apr 2026 15
- Neuraxis (NRXS) CEO boosts stake with open-market buy of 8,060 shares - Stock Titan Fri, 03 Apr 2026 15
- $NRXS ($NRXS) Releases Q4 2025 Earnings - Quiver Quantitative hu, 19 Mar 2026 07
- Neuraxis CEO Carrico buys $15,797 in company stock - Investing.com Fri, 03 Apr 2026 15
- Medical tech firm NeurAxis schedules March 19 call on 2025 results - Stock Titan hu, 12 Mar 2026 07
- Neuraxis Inc: CRO Carrico buys $1307 in shares By Investing.com - Investing.com South Africa Fri, 03 Apr 2026 16
Insider Transactions
Financials
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
3.57
+32.89%
|
2.69
+9.18%
|
2.46
-8.37%
|
2.68
|
| Operating Revenue |
|
3.57
+32.89%
|
2.69
+9.18%
|
2.46
-8.37%
|
2.68
|
| Cost Of Revenue |
|
0.56
+55.50%
|
0.36
+19.34%
|
0.30
+2.12%
|
0.30
|
| Reconciled Cost Of Revenue |
|
0.56
+55.50%
|
0.36
+19.34%
|
0.30
+2.12%
|
0.30
|
| Gross Profit |
|
3.01
+29.37%
|
2.32
+7.75%
|
2.16
-9.67%
|
2.39
|
| Operating Expense |
|
10.84
+14.30%
|
9.48
+7.48%
|
8.82
+53.15%
|
5.76
|
| Research And Development |
|
0.49
+13.84%
|
0.43
+156.10%
|
0.17
-24.95%
|
0.23
|
| Selling General And Administration |
|
10.34
+14.32%
|
9.05
+4.57%
|
8.65
+56.33%
|
5.53
|
| Selling And Marketing Expense |
|
2.28
+55.22%
|
1.47
+353.96%
|
0.32
-21.25%
|
0.41
|
| General And Administrative Expense |
|
8.06
+6.39%
|
7.58
-9.01%
|
8.33
+62.55%
|
5.12
|
| Other Gand A |
|
8.06
+6.39%
|
7.58
-9.01%
|
8.33
+62.55%
|
5.12
|
| Total Expenses |
|
11.40
+15.81%
|
9.84
+7.87%
|
9.12
+50.65%
|
6.06
|
| Operating Income |
|
-7.83
-9.40%
|
-7.16
-7.39%
|
-6.66
-97.63%
|
-3.37
|
| Total Operating Income As Reported |
|
-7.83
-9.40%
|
-7.16
-7.39%
|
-6.66
-97.63%
|
-3.37
|
| EBITDA |
|
-7.67
+2.98%
|
-7.90
+14.36%
|
-9.23
-113.35%
|
-4.33
|
| Normalized EBITDA |
|
-7.66
+3.07%
|
-7.90
-19.33%
|
-6.62
-17.30%
|
-5.65
|
| Reconciled Depreciation |
|
0.06
+57.28%
|
0.04
-7.11%
|
0.04
+9.67%
|
0.04
|
| EBIT |
|
-7.73
+2.70%
|
-7.94
+14.33%
|
-9.27
-112.46%
|
-4.36
|
| Total Unusual Items |
|
-0.01
-711.26%
|
-0.00
+99.96%
|
-2.61
-297.43%
|
1.32
|
| Total Unusual Items Excluding Goodwill |
|
-0.01
-711.26%
|
-0.00
+99.96%
|
-2.61
-297.43%
|
1.32
|
| Special Income Charges |
|
0.00
|
0.00
+100.00%
|
-3.65
|
0.00
|
| Other Special Charges |
|
—
|
—
|
3.65
|
—
|
| Net Income |
|
-7.80
+5.35%
|
-8.24
+43.65%
|
-14.63
-205.99%
|
-4.78
|
| Pretax Income |
|
-7.80
+5.35%
|
-8.24
+43.65%
|
-14.63
-205.99%
|
-4.78
|
| Net Non Operating Interest Income Expense |
|
-0.10
+80.39%
|
-0.53
+90.08%
|
-5.36
-95.66%
|
-2.74
|
| Interest Expense Non Operating |
|
0.07
-75.40%
|
0.30
-94.39%
|
5.36
+1183.05%
|
0.42
|
| Net Interest Income |
|
-0.10
+80.39%
|
-0.53
+90.08%
|
-5.36
-95.66%
|
-2.74
|
| Interest Expense |
|
0.07
-75.40%
|
0.30
-94.39%
|
5.36
+1183.05%
|
0.42
|
| Interest Income Non Operating |
|
—
|
—
|
—
|
—
|
| Interest Income |
|
—
|
—
|
—
|
—
|
| Other Income Expense |
|
0.13
+124.15%
|
-0.55
+78.74%
|
-2.60
-295.30%
|
1.33
|
| Other Non Operating Income Expenses |
|
0.14
+125.57%
|
-0.55
-11657.22%
|
0.00
-60.04%
|
0.01
|
| Gain On Sale Of Security |
|
-0.01
-711.26%
|
-0.00
-100.09%
|
1.04
-20.96%
|
1.32
|
| Tax Rate For Calcs |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Tax Effect Of Unusual Items |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Net Income Including Noncontrolling Interests |
|
-7.80
+5.35%
|
-8.24
+43.65%
|
-14.63
-205.99%
|
-4.78
|
| Net Income From Continuing Operation Net Minority Interest |
|
-7.80
+5.35%
|
-8.24
+43.65%
|
-14.63
-205.99%
|
-4.78
|
| Net Income From Continuing And Discontinued Operation |
|
-7.80
+5.35%
|
-8.24
+43.65%
|
-14.63
-205.99%
|
-4.78
|
| Net Income Continuous Operations |
|
-7.80
+5.35%
|
-8.24
+43.65%
|
-14.63
-205.99%
|
-4.78
|
| Normalized Income |
|
-7.79
+5.43%
|
-8.24
+31.45%
|
-12.02
-97.05%
|
-6.10
|
| Net Income Common Stockholders |
|
-8.62
-1.92%
|
-8.45
+42.21%
|
-14.63
-163.78%
|
-5.54
|
| Diluted EPS |
|
—
|
-1.22
+45.71%
|
-2.25
-148.83%
|
-0.90
|
| Basic EPS |
|
—
|
-1.22
+45.71%
|
-2.25
-148.83%
|
-0.90
|
| Basic Average Shares |
|
—
|
6.92
+6.30%
|
6.51
+6.01%
|
6.14
|
| Diluted Average Shares |
|
—
|
6.92
+6.30%
|
6.51
-22.63%
|
8.41
|
| Diluted NI Availto Com Stockholders |
|
-8.62
-1.92%
|
-8.45
+42.21%
|
-14.63
-163.78%
|
-5.54
|
| Preferred Stock Dividends |
|
0.81
+285.58%
|
0.21
|
—
|
0.76
|
| Total Other Finance Cost |
|
0.03
-86.90%
|
0.23
+8226.98%
|
0.00
-99.88%
|
2.32
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Assets |
|
6.40
+34.61%
|
4.76
+833.78%
|
0.51
-65.59%
|
1.48
|
| Current Assets |
|
5.73
+34.39%
|
4.27
+1658.45%
|
0.24
-49.13%
|
0.48
|
| Cash Cash Equivalents And Short Term Investments |
|
4.97
+34.30%
|
3.70
+4605.79%
|
0.08
-69.03%
|
0.25
|
| Cash And Cash Equivalents |
|
4.97
+34.30%
|
3.70
+4605.79%
|
0.08
-69.03%
|
0.25
|
| Cash Financial |
|
4.97
+34.30%
|
3.70
+4605.79%
|
0.08
|
—
|
| Receivables |
|
0.20
-20.00%
|
0.24
+234.33%
|
0.07
-58.05%
|
0.17
|
| Accounts Receivable |
|
0.20
-20.00%
|
0.24
+234.33%
|
0.07
-58.05%
|
0.17
|
| Gross Accounts Receivable |
|
0.20
-18.66%
|
0.25
+193.12%
|
0.09
|
—
|
| Allowance For Doubtful Accounts Receivable |
|
-0.01
-46.52%
|
-0.01
+58.31%
|
-0.01
|
—
|
| Inventory |
|
0.26
+480.07%
|
0.04
+108.90%
|
0.02
-55.91%
|
0.05
|
| Prepaid Assets |
|
0.24
+8.34%
|
0.23
|
—
|
—
|
| Other Current Assets |
|
0.07
+29.52%
|
0.05
-21.76%
|
0.07
+9495.45%
|
0.00
|
| Total Non Current Assets |
|
0.67
+36.52%
|
0.49
+84.12%
|
0.27
-73.41%
|
1.00
|
| Net PPE |
|
0.34
-10.01%
|
0.37
+135.90%
|
0.16
-16.15%
|
0.19
|
| Gross PPE |
|
0.64
-14.02%
|
0.75
+47.78%
|
0.51
-0.07%
|
0.51
|
| Accumulated Depreciation |
|
-0.31
+18.03%
|
-0.37
-7.57%
|
-0.35
-9.51%
|
-0.32
|
| Properties |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Buildings And Improvements |
|
0.26
-8.11%
|
0.28
+305.13%
|
0.07
-30.69%
|
0.10
|
| Machinery Furniture Equipment |
|
0.38
-13.73%
|
0.44
+6.68%
|
0.42
+8.00%
|
0.38
|
| Other Properties |
|
—
|
—
|
0.07
-30.69%
|
0.10
|
| Leases |
|
0.00
-100.00%
|
0.02
+0.00%
|
0.02
+0.00%
|
0.02
|
| Goodwill And Other Intangible Assets |
|
0.27
+184.48%
|
0.10
-10.63%
|
0.11
+39.34%
|
0.08
|
| Other Intangible Assets |
|
0.27
+184.48%
|
0.10
-10.63%
|
0.11
+39.34%
|
0.08
|
| Non Current Deferred Assets |
|
0.02
|
0.00
|
0.00
-100.00%
|
0.74
|
| Non Current Prepaid Assets |
|
0.04
+73.96%
|
0.02
|
0.00
|
—
|
| Total Liabilities Net Minority Interest |
|
3.00
+11.70%
|
2.69
+40.63%
|
1.91
-72.89%
|
7.05
|
| Current Liabilities |
|
2.79
+14.74%
|
2.43
+29.04%
|
1.89
-72.98%
|
6.98
|
| Payables And Accrued Expenses |
|
0.48
-47.46%
|
0.91
-28.18%
|
1.27
-32.59%
|
1.89
|
| Payables |
|
0.14
-76.65%
|
0.60
-50.43%
|
1.20
-24.36%
|
1.59
|
| Accounts Payable |
|
0.14
-76.65%
|
0.60
-50.43%
|
1.20
-24.36%
|
1.59
|
| Current Accrued Expenses |
|
0.34
+7.61%
|
0.32
+368.06%
|
0.07
-77.04%
|
0.29
|
| Pensionand Other Post Retirement Benefit Plans Current |
|
1.36
+7.82%
|
1.26
+278.23%
|
0.33
-38.19%
|
0.54
|
| Total Tax Payable |
|
—
|
—
|
—
|
0.00
|
| Current Debt And Capital Lease Obligation |
|
0.21
-1.32%
|
0.22
+10.00%
|
0.20
-62.27%
|
0.52
|
| Current Debt |
|
0.15
-3.80%
|
0.15
+4.11%
|
0.15
-69.74%
|
0.49
|
| Other Current Borrowings |
|
—
|
—
|
—
|
0.23
|
| Current Capital Lease Obligation |
|
0.07
+4.78%
|
0.06
+27.74%
|
0.05
+47.11%
|
0.03
|
| Current Deferred Liabilities |
|
0.03
-11.89%
|
0.03
-56.60%
|
0.07
+26.66%
|
0.06
|
| Current Deferred Revenue |
|
0.03
-11.89%
|
0.03
-56.60%
|
0.07
+26.66%
|
0.06
|
| Other Current Liabilities |
|
0.02
+83.29%
|
0.01
+11.44%
|
0.01
-99.79%
|
3.97
|
| Total Non Current Liabilities Net Minority Interest |
|
0.21
-17.13%
|
0.26
+847.50%
|
0.03
-64.47%
|
0.08
|
| Long Term Debt And Capital Lease Obligation |
|
0.20
-21.03%
|
0.26
+847.50%
|
0.03
-64.47%
|
0.08
|
| Long Term Debt |
|
—
|
—
|
—
|
—
|
| Long Term Capital Lease Obligation |
|
0.20
-21.03%
|
0.26
+847.50%
|
0.03
-64.47%
|
0.08
|
| Other Non Current Liabilities |
|
0.01
|
—
|
—
|
—
|
| Stockholders Equity |
|
3.40
+64.40%
|
2.07
+247.36%
|
-1.40
+74.82%
|
-5.57
|
| Common Stock Equity |
|
3.40
+64.56%
|
2.06
+247.05%
|
-1.40
+74.83%
|
-5.57
|
| Capital Stock |
|
0.01
+28.21%
|
0.01
+73.16%
|
0.01
+151.80%
|
0.00
|
| Common Stock |
|
0.01
+52.40%
|
0.01
+7.39%
|
0.01
+231.58%
|
0.00
|
| Preferred Stock |
|
0.00
-11.31%
|
0.00
|
0.00
-100.00%
|
0.00
|
| Share Issued |
|
10.65
+52.40%
|
6.99
+7.39%
|
6.51
+7.73%
|
6.04
|
| Ordinary Shares Number |
|
10.65
+52.40%
|
6.99
+7.39%
|
6.51
+7.73%
|
6.04
|
| Additional Paid In Capital |
|
67.99
+15.51%
|
58.86
+24.83%
|
47.15
+66.28%
|
28.36
|
| Retained Earnings |
|
-64.60
-13.73%
|
-56.80
-16.97%
|
-48.56
-43.11%
|
-33.93
|
| Total Equity Gross Minority Interest |
|
3.40
+64.40%
|
2.07
+247.36%
|
-1.40
+74.82%
|
-5.57
|
| Total Capitalization |
|
3.40
+64.40%
|
2.07
+247.36%
|
-1.40
+74.82%
|
-5.57
|
| Working Capital |
|
2.94
+60.46%
|
1.83
+211.55%
|
-1.64
+74.73%
|
-6.50
|
| Invested Capital |
|
3.54
+59.81%
|
2.22
+276.68%
|
-1.26
+75.32%
|
-5.09
|
| Total Debt |
|
0.42
-12.00%
|
0.47
+111.10%
|
0.22
-62.55%
|
0.60
|
| Net Debt |
|
—
|
—
|
0.07
-70.49%
|
0.24
|
| Capital Lease Obligations |
|
0.27
-15.95%
|
0.32
+318.98%
|
0.08
-30.47%
|
0.11
|
| Net Tangible Assets |
|
3.12
+58.52%
|
1.97
+230.43%
|
-1.51
+73.26%
|
-5.65
|
| Tangible Book Value |
|
3.12
+58.67%
|
1.97
+230.14%
|
-1.51
+73.26%
|
-5.65
|
| Current Notes Payable |
|
0.15
-3.80%
|
0.15
+4.11%
|
0.15
-43.25%
|
0.26
|
| Current Provisions |
|
0.69
|
—
|
—
|
—
|
| Interest Payable |
|
0.07
+0.00%
|
0.07
+0.00%
|
0.07
-67.56%
|
0.21
|
| Inventories Adjustments Allowances |
|
-0.03
-675.12%
|
-0.00
|
—
|
—
|
| Other Inventories |
|
0.29
+497.88%
|
0.05
|
—
|
—
|
| Preferred Stock Equity |
|
0.00
-11.31%
|
0.00
|
—
|
0.00
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
-6.43
-5.49%
|
-6.10
+8.90%
|
-6.69
-191.30%
|
-2.30
|
| Cash Flow From Continuing Operating Activities |
|
-6.43
-5.49%
|
-6.10
+8.90%
|
-6.69
-191.30%
|
-2.30
|
| Net Income From Continuing Operations |
|
-7.80
+5.35%
|
-8.24
+43.65%
|
-14.63
-205.99%
|
-4.78
|
| Depreciation Amortization Depletion |
|
0.06
+57.28%
|
0.04
-7.11%
|
0.04
+9.67%
|
0.04
|
| Depreciation And Amortization |
|
0.06
+57.28%
|
0.04
-7.11%
|
0.04
+9.67%
|
0.04
|
| Other Non Cash Items |
|
0.05
-86.30%
|
0.39
-92.48%
|
5.18
+111.47%
|
2.45
|
| Stock Based Compensation |
|
0.60
-57.49%
|
1.40
+87.22%
|
0.75
+2645.34%
|
0.03
|
| Provisionand Write Offof Assets |
|
0.03
+173.41%
|
0.01
-53.13%
|
0.03
+29.61%
|
0.02
|
| Operating Gains Losses |
|
0.02
-90.22%
|
0.16
-93.91%
|
2.61
+297.43%
|
-1.32
|
| Gain Loss On Investment Securities |
|
0.01
-95.19%
|
0.16
+115.21%
|
-1.04
+20.96%
|
-1.32
|
| Gain Loss On Sale Of PPE |
|
0.01
|
0.00
|
—
|
—
|
| Change In Working Capital |
|
0.61
+331.49%
|
0.14
+121.24%
|
-0.67
-152.40%
|
1.27
|
| Change In Receivables |
|
0.05
+126.05%
|
-0.18
-335.47%
|
0.08
+196.63%
|
-0.08
|
| Changes In Account Receivables |
|
0.05
+126.05%
|
-0.18
-335.47%
|
0.08
+196.63%
|
-0.08
|
| Change In Inventory |
|
-0.24
-647.30%
|
-0.03
-220.76%
|
0.03
+400.60%
|
-0.01
|
| Change In Prepaid Assets |
|
0.24
+1626.05%
|
0.01
+125.84%
|
-0.05
-1211.98%
|
0.00
|
| Change In Payables And Accrued Expense |
|
0.63
+82.57%
|
0.34
+150.20%
|
-0.68
-149.40%
|
1.38
|
| Change In Accrued Expense |
|
1.08
+14.01%
|
0.95
+422.86%
|
-0.29
-207.98%
|
0.27
|
| Change In Payable |
|
-0.46
+24.65%
|
-0.61
-56.56%
|
-0.39
-135.00%
|
1.11
|
| Change In Account Payable |
|
-0.46
+24.65%
|
-0.61
-56.56%
|
-0.39
-135.00%
|
1.11
|
| Change In Other Working Capital |
|
—
|
—
|
0.02
+255.20%
|
-0.01
|
| Change In Other Current Liabilities |
|
-0.06
-1535.85%
|
-0.00
+89.78%
|
-0.03
-21.08%
|
-0.03
|
| Investing Cash Flow |
|
-0.13
-372.17%
|
-0.03
+61.30%
|
-0.07
-17.28%
|
-0.06
|
| Cash Flow From Continuing Investing Activities |
|
-0.13
-372.17%
|
-0.03
+61.30%
|
-0.07
-17.28%
|
-0.06
|
| Net PPE Purchase And Sale |
|
-0.03
-12.15%
|
-0.03
+9.76%
|
-0.03
-2114.46%
|
-0.00
|
| Purchase Of PPE |
|
-0.03
-12.15%
|
-0.03
+9.76%
|
-0.03
-2114.46%
|
-0.00
|
| Capital Expenditure |
|
-0.13
-372.17%
|
-0.03
+61.30%
|
-0.07
-17.28%
|
-0.06
|
| Net Intangibles Purchase And Sale |
|
-0.10
|
0.00
+100.00%
|
-0.04
+31.46%
|
-0.06
|
| Purchase Of Intangibles |
|
-0.10
|
0.00
+100.00%
|
-0.04
+31.46%
|
-0.06
|
| Financing Cash Flow |
|
7.83
-19.62%
|
9.74
+47.85%
|
6.59
+187.54%
|
2.29
|
| Cash Flow From Continuing Financing Activities |
|
7.83
-19.62%
|
9.74
+48.30%
|
6.57
+186.67%
|
2.29
|
| Net Issuance Payments Of Debt |
|
-0.28
-106.05%
|
4.66
+125.50%
|
2.07
-34.59%
|
3.16
|
| Issuance Of Debt |
|
0.00
-100.00%
|
4.94
-12.19%
|
5.62
+69.17%
|
3.32
|
| Repayment Of Debt |
|
-0.28
-2.09%
|
-0.28
+92.23%
|
-3.55
-2077.37%
|
-0.16
|
| Long Term Debt Issuance |
|
—
|
—
|
—
|
0.12
|
| Long Term Debt Payments |
|
—
|
—
|
—
|
-0.16
|
| Net Long Term Debt Issuance |
|
—
|
—
|
—
|
-0.04
|
| Short Term Debt Issuance |
|
0.00
-100.00%
|
4.94
-12.19%
|
5.62
+69.17%
|
3.32
|
| Short Term Debt Payments |
|
-0.28
-2.09%
|
-0.28
+92.23%
|
-3.55
-2077.37%
|
-0.16
|
| Net Short Term Debt Issuance |
|
-0.28
-106.05%
|
4.66
+125.50%
|
2.07
-34.59%
|
3.16
|
| Net Common Stock Issuance |
|
7.73
|
0.00
-100.00%
|
4.85
|
0.00
|
| Proceeds From Stock Option Exercised |
|
1.10
+4094.77%
|
0.03
-87.48%
|
0.21
|
0.00
|
| Net Other Financing Charges |
|
-0.71
-266.41%
|
-0.19
+63.44%
|
-0.53
+38.62%
|
-0.87
|
| Changes In Cash |
|
1.27
-64.95%
|
3.62
+2165.96%
|
-0.18
-160.78%
|
-0.07
|
| Beginning Cash Position |
|
3.70
+4605.79%
|
0.08
-69.03%
|
0.25
-20.93%
|
0.32
|
| End Cash Position |
|
4.97
+34.30%
|
3.70
+4605.79%
|
0.08
-69.03%
|
0.25
|
| Free Cash Flow |
|
-6.56
-7.15%
|
-6.13
+9.46%
|
-6.77
-186.78%
|
-2.36
|
| Interest Paid Supplemental Data |
|
0.01
-64.96%
|
0.03
-84.23%
|
0.21
+5.81%
|
0.20
|
| Income Tax Paid Supplemental Data |
|
0.01
+29.28%
|
0.01
|
0.00
|
0.00
|
| Common Stock Issuance |
|
7.73
|
0.00
-100.00%
|
4.85
|
0.00
|
| Issuance Of Capital Stock |
|
7.73
+47.11%
|
5.25
+8.38%
|
4.85
|
0.00
|
| Net Preferred Stock Issuance |
|
0.00
-100.00%
|
5.25
|
0.00
|
0.00
|
| Preferred Stock Issuance |
|
0.00
-100.00%
|
5.25
|
0.00
|
0.00
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 42026-04-03 View
- 42026-04-03 View
- 42026-04-03 View
- 10-K2026-03-19 View
- 42026-03-02 View
- 42026-02-26 View
- 42026-02-26 View
- 42026-02-26 View
- 42026-02-26 View
- 42026-02-26 View
- 42026-02-13 View
- 42026-01-30 View
- 42026-01-30 View
- 42025-12-29 View
- 10-Q2025-11-10 View
- 8-K2025-10-24 View
- 8-K2025-10-23 View
- 42025-09-10 View
- 42025-09-10 View
- 42025-09-10 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|